Nanovaccines: Immunogenic tumor antigens, targeted delivery, and combination therapy to enhance cancer immunotherapy

Documenti analoghi

• Proteolysis‐targeting chimeras in antiviral therapy: Leveraging influenza virus and exosome‐mediated delivery for targeted protein degradation and therapeutic advancements
  di: Nobendu Mukerjee, et al.
  Pubblicazione: (2024)
• EGCG enhances antitumor effect of apatinib in nonsmall cell lung cancer by targeting VEGF signaling to inhibit glycolysis
  di: Yue Zhou, et al.
  Pubblicazione: (2024)
• Newly synthesized acridone derivatives targeting lung cancer: A toxicity and xenograft model study
  di: Nilam Bhusare, et al.
  Pubblicazione: (2024)
• YTHDF2 promotes gastric cancer progression and enhances chemoradiotherapy resistance
  di: Jian Yang, et al.
  Pubblicazione: (2024)
• Exploring chromone‐2‐carboxamide derivatives for triple‐negative breast cancer targeting EGFR, FGFR3, and VEGF pathways: Design, synthesis, and preclinical insights
  di: Dalia S. El‐Gamil, et al.
  Pubblicazione: (2024)